Antimicrobial Agents and Chemotherapy · 1999 · 51 citations · 8 references
Life SciencesMicrobiologyPharmacologyAntimicrobial PharmacologyAntimicrobial ResistanceMedical MicrobiologyAntibacterial PharmacologyAntibacterial PharmacotherapyAntibacterial TherapyAntibiotic ResistanceBacterial InfectionsCombination Antimicrobial TherapyAntibiotic CombinationsAntibiotic Mechanisms Of ActionBactericidal AgentsVancomycin-intermediate Resistance
This in vitro study evaluated the activities of vancomycin, LY333328, and teicoplanin alone and in combination with gentamicin, rifampin, and RP59500 against Staphylococcus aureus isolates with intermediate susceptibilities to vancomycin. Ampicillin-sulbactam and trovafloxacin were also evaluated. LY333328 and ampicillin-sulbactam resulted in bactericidal activity against all isolates. The combination of gentamicin with glycopeptides showed synergistic activity, while rifampin had no added benefit.
8
John Vincent, Jürgen Venitz, Rongyue Teng et al. · Journal of Antimicrobial Chemotherapy · 1997 · 65 citations · Full text